IBTK
Inhibitor of Bruton tyrosine kinase
Also known as: BTBD26, BTKI, DKFZP564B116, IBTK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2D0
- Gene
- IBTK
- Ensembl
- ENSG00000005700
- Chromosome
- 6
- Canonical length
- 1353 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Bruton tyrosine kinase (BTK) is a protein tyrosine kinase that is expressed in B cells, macrophages, and neutrophils. The protein encoded by this gene binds to BTK and downregulates BTK's kinase activity. In addition, the encoded protein disrupts BTK-mediated calcium mobilization and negatively regulates the activation of nuclear factor-kappa-B-driven transcription. This gene has a pseudogene on chromosome 18. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
1353 residues, UniProt reviewed canonical sequence.
>Q9P2D0|IBTK
1 MSSPMPDCTS KCRSLKHALD VLSVVTKGSE NQIKAFLSSH CYNAATIKDV FGRNALHLVS
61 SCGKKGVLDW LIQKGVDLLV KDKESGWTAL HRSIFYGHID CVWSLLKHGV SLYIQDKEGL
121 SALDLVMKDR PTHVVFKNTD PTDVYTWGDN TNFTLGHGSQ NSKHHPELVD LFSRSGIYIK
181 QVVLCKFHSV FLSQKGQVYT CGHGPGGRLG HGDEQTCLVP RLVEGLNGHN CSQVAAAKDH
241 TVVLTEDGCV YTFGLNIFHQ LGIIPPPSSC NVPRQIQAKY LKGRTIIGVA AGRFHTVLWT
301 REAVYTMGLN GGQLGCLLDP NGEKCVTAPR QVSALHHKDI ALSLVAASDG ATVCVTTRGD
361 IYLLADYQCK KMASKQLNLK KVLVSGGHME YKVDPEHLKE NGGQKICILA MDGAGRVFCW
421 RSVNSSLKQC RWAYPRQVFI SDIALNRNEI LFVTQDGEGF RGRWFEEKRK SSEKKEILSN
481 LHNSSSDVSY VSDINSVYER IRLEKLTFAH RAVSVSTDPS GCNFAILQSD PKTSLYEIPA
541 VSSSSFFEEF GKLLREADEM DSIHDVTFQV GNRLFPAHKY ILAVHSDFFQ KLFLSDGNTS
601 EFTDIYQKDE DSAGCHLFVV EKVHPDMFEY LLQFIYTDTC DFLTHGFKPR IHLNKNPEEY
661 QGTLNSHLNK VNFHEDDNQK SAFEVYKSNQ AQTVSERQKS KPKSCKKGKN IREDDPVRML
721 QTVAKKFDFS NLSSRLDGVR FENEKINVIA KNTGNKLKLS QKKCSFLCDV TMKSVDGKEF
781 PCHKCVLCAR LEYFHSMLSS SWIEASSCAA LEMPIHSDIL KVILDYLYTD EAVVIKESQN
841 VDFICSVLVV ADQLLITRLK EICEVALTEK LTLKNAAMLL EFAAMYSAKQ LKLSCLQFIG
901 LNMAALLEAR SLDVLSDGVL KDLSEFYRKM IPAMDRRVIT PYQDGPDISY LEVEDGDIFL
961 KEEINMEQNH SETMFKKAKT KAKKKPRKRS DSSGGYNLSD IIQSPSSTGL LKSGKTNSVE
1021 SLPELLTSDS EGSYAGVGSP RDLQSPDFTT GFHSDKIEAK VKPYVNGTSP VYSREDLKPW
1081 EKSPILKISA PQPIPSNRID TTSSASWVAG SFSPVSPPVV DLRTIMEIEE SRQKCGATPK
1141 SHLGKTVSHG VKLSQKQRKM IALTTKENNS GMNSMETVLF TPSKAPKPVN AWASSLHSVS
1201 SKSFRDFLLE EKKSVTSHSS GDHVKKVSFK GIENSQAPKI VRCSTHGTPG PEGNHISDLP
1261 LLDSPNPWLS SSVTAPSMVA PVTFASIVEE ELQQEAALIR SREKPLALIQ IEEHAIQDLL
1321 VFYEAFGNPE EFVIVERTPQ GPLAVPMWNK HGCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IBTK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- liver: 21 nTPM
- skeletal muscle: 20 nTPM
- tongue: 20 nTPM
- adrenal gland: 13 nTPM
- parathyroid gland: 12 nTPM
- stomach: 11 nTPM
Single-cell type
- oligodendrocytes: 185 nCPM
- microglia: 144 nCPM
- choroid plexus epithelial cells: 142 nCPM
- brain inhibitory neurons: 126 nCPM
- brain excitatory neurons: 119 nCPM
- distal convoluted tubule cells: 117 nCPM
Immune cell
- T-reg: 2.7 nTPM
- MAIT T-cell: 2.4 nTPM
- non-classical monocyte: 2.3 nTPM
- myeloid DC: 1.9 nTPM
- gdT-cell: 1.8 nTPM
- memory CD4 T-cell: 1.8 nTPM
Brain region
- spinal cord: 8.9 nTPM
- white matter: 8.6 nTPM
- midbrain: 8.5 nTPM
- thalamus: 8.2 nTPM
- basal ganglia: 8.1 nTPM
- cerebellum: 8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.28
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Regulator of chromosome condensation, RCC1
- Ankyrin repeat
- Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II
- SKP1/BTB/POZ domain superfamily
- Ankyrin repeat-containing domain superfamily
- Diverse Signaling and Regulatory Domain-Containing Protein
- Regulator of chromosome condensation (RCC1) repeat
- BTB/POZ domain
- Ankyrin repeats (3 copies)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IBTK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IBTK as an antibody target. Whether an autoantibody or antibody against IBTK could matter depends on whether native IBTK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IBTK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IBTK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...